Effects of Laparoscopic Myotomy on the Esophageal Motility Pattern of Esophageal Achalasia As Measured by High-resolution Manometry
Overview
General Surgery
Radiology
Authors
Affiliations
Background: Esophageal achalasia can be classified on the grounds of three distinct manometric patterns that correlate well with final outcome after laparoscopic Heller-Dor myotomy (LHM). No analytical data are available, however, on the postoperative picture and its possible correlation with final outcome. The aims of this study were: (a) to investigate whether manometric patterns change after LHM for achalasia; (b) to ascertain whether postoperative patterns and/or changes can predict final outcome; and (c) to test the hypothesis that the three known patterns represent different stages in the evolution of the disease.
Methods: During the study period, we prospectively enlisted 206 consecutive achalasia patients who were assessed using high-resolution manometry (HRM) before undergoing LHM. Symptoms were scored using a detailed questionnaire. Barium swallow, endoscopy and HRM were performed, before and again 6 months after surgery.
Results: Preoperative HRM revealed the three known patterns with statistically different esophageal diameters (pattern I having the largest), and patients with pattern I had the highest symptom scores. The surgical treatment failed in 10 cases (4.9%). The only predictor of final outcome was the preoperative manometric pattern (p = 0.01). All patients with pattern I preoperatively had the same pattern afterward, whereas nearly 50% of patients with pattern III before LHM had patterns I or II after surgery. There were no cases showing the opposite trend.
Conclusions: Neither a change of manometric pattern after surgery nor a patient's postoperative pattern was a predictor of final outcome, whereas preoperative pattern confirmed its prognostic significance. The three manometric patterns distinguishable in achalasia may represent different stages in the disease's evolution, pattern III and pattern I coinciding with the early and final stages of the disease, respectively.
Vespa E, Farina D, Pandolfino J, Kahrilas P, Koop A, Carlson D Neurogastroenterol Motil. 2023; 36(3):e14732.
PMID: 38155413 PMC: 10922458. DOI: 10.1111/nmo.14732.
Kulkarni A, Ghoshal U, Shirol V, Elhence A, Fatima B, Agrahari A Indian J Gastroenterol. 2023; 42(4):549-557.
PMID: 37306890 DOI: 10.1007/s12664-023-01372-6.
Vespa E, Farina D, Kahrilas P, Kou W, Low E, Yadlapati R Neurogastroenterol Motil. 2023; 35(7):e14552.
PMID: 36807659 PMC: 10330382. DOI: 10.1111/nmo.14552.
Tatsuta T, Sato H, Fujiyoshi Y, Abe H, Shiwaku A, Shiota J J Neurogastroenterol Motil. 2022; 28(4):562-571.
PMID: 36250363 PMC: 9577579. DOI: 10.5056/jnm21254.
Savarino E, Bhatia S, Roman S, Sifrim D, Tack J, Thompson S Nat Rev Dis Primers. 2022; 8(1):28.
PMID: 35513420 DOI: 10.1038/s41572-022-00356-8.